A long term, double-blind, randomized, parallel-group, carbidopa/levodopa controlled, multi-center study to evaluate the effect of Stalevo in patients with Parkinson's disease requiring initiation of levodopa therapy.
Phase of Trial: Phase III
Latest Information Update: 16 Jan 2015
At a glance
- Drugs Levodopa/carbidopa; Levodopa/carbidopa/entacapone
- Indications Drug-induced dyskinesia; Parkinson's disease
- Focus Adverse reactions
- Acronyms STRIDE-PD
- 31 Aug 2018 Biomarkers information updated
- 07 Mar 2011 Last checked against ClinicalTrials.gov record.
- 17 Feb 2009 Primary endpoint 'Time to disease progression' has not been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History